Cargando…

A Practical Review of Proteasome Pharmacology

The ubiquitin proteasome system (UPS) degrades individual proteins in a highly regulated fashion and is responsible for the degradation of misfolded, damaged, or unneeded cellular proteins. During the past 20 years, investigators have established a critical role for the UPS in essentially every cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thibaudeau, Tiffany A., Smith, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423620/ https://www.ncbi.nlm.nih.gov/pubmed/30867233 http://dx.doi.org/10.1124/pr.117.015370

Ejemplares similares

A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
por: Thibaudeau, Tiffany A., et al.
Publicado: (2018)

Minimal mechanistic component of HbYX-dependent proteasome activation
por: Chuah, Janelle J., et al.
Publicado: (2023)

Minimal mechanistic component of HbYX-dependent proteasome activation that reverses impairment by neurodegenerative-associated oligomers
por: Chuah, Janelle J. Y., et al.
Publicado: (2023)

Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
por: Sharma, Anmol, et al.
Publicado: (2021)

Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
por: Gupta, Neeraj, et al.
Publicado: (2018)

Structure, Function, and Allosteric Regulation of the 20S Proteasome by the 11S/PA28 Family of Proteasome Activators
por: Thomas, Taylor, et al.
Publicado: (2023)

Modelling Proteasome and Proteasome Regulator Activities
por: Liepe, Juliane, et al.
Publicado: (2014)

Deubiquitination Reactions on the Proteasome for Proteasome Versatility
por: Shin, Ji Yeong, et al.
Publicado: (2020)

Proteasome in action: substrate degradation by the 26S proteasome
por: Sahu, Indrajit, et al.
Publicado: (2021)

Pharmacology in Clinical Practice
Publicado: (1953)

The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016)

The proteasome and the degradation of oxidized proteins: Part I—structure of proteasomes()
por: Jung, Tobias, et al.
Publicado: (2013)

Role of proteasomes in disease
por: Dahlmann, Burkhardt
Publicado: (2007)

Functions of the Proteasome on Chromatin
por: McCann, Tyler S., et al.
Publicado: (2014)

Proteasome inhibitors in glioblastoma
por: Huang, Wen-Juan, et al.
Publicado: (2017)

Role of Proteasomes in Inflammation
por: Goetzke, Carl Christoph, et al.
Publicado: (2021)

Biology of the Extracellular Proteasome
por: Ben-Nissan, Gili, et al.
Publicado: (2022)

Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?
por: Kim, Kyung Bo
Publicado: (2021)

Practical manual of pharmacology
por: Desai, Chetna
Publicado: (2008)

Practical Manual of Pharmacology for Medical Students: Book Review
por: Mahajan, Rajiv
Publicado: (2021)

The recognition of ubiquitinated proteins by the proteasome
por: Grice, Guinevere L., et al.
Publicado: (2016)

Proteasome regulators in pancreatic cancer
por: Murugan, Nirosha J, et al.
Publicado: (2022)

GENETIC AND PHARMACOLOGIC PROTEASOME AUGMENTATION AMELIORATES ALZHEIMER’S-LIKE PATHOLOGY IN MICE AND FLIES
por: Pickering, Andrew
Publicado: (2022)

The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?
por: Schipper-Krom, Sabine, et al.
Publicado: (2012)

The Contribution of the 20S Proteasome to Proteostasis
por: Kumar Deshmukh, Fanindra, et al.
Publicado: (2019)

Genetics of Proteasome Diseases
por: Gomes, Aldrin V.
Publicado: (2013)

The proteasome and the degradation of oxidized proteins: Part II – protein oxidation and proteasomal degradation
por: Jung, Tobias, et al.
Publicado: (2013)

Proteins Directly Interacting with Mammalian 20S Proteasomal Subunits and Ubiquitin-Independent Proteasomal Degradation
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2014)

Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
por: Lobbestael, E., et al.
Publicado: (2016)

Proteasome activator 28γ (PA28γ) allosterically activates trypsin-like proteolysis by binding to the α-ring of the 20S proteasome
por: Thomas, Taylor A., et al.
Publicado: (2022)

Role of the Ubiquitin Proteasome System in the Regulation of Blood Pressure: A Review
por: Yamazaki, Osamu, et al.
Publicado: (2020)

Active ingredients are reported more often for pharmacologic than non-pharmacologic interventions: an illustrative review of reporting practices in titles and abstracts
por: McCleary, Nicola, et al.
Publicado: (2013)

Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease
por: Sherman, David J., et al.
Publicado: (2020)

Proteasome Activation to Combat Proteotoxicity
por: Jones, Corey L., et al.
Publicado: (2019)

The Hunt for Degrons of the 26S Proteasome
por: Ella, Hadar, et al.
Publicado: (2019)

The ubiquitin proteasome system in neuropathology
por: Lehman, Norman L.
Publicado: (2009)

The proteasome: Overview of structure and functions
por: Tanaka, Keiji
Publicado: (2009)

Nuclear Transport of Yeast Proteasomes
por: Enenkel, Cordula
Publicado: (2014)

Nuclear Import of Yeast Proteasomes
por: Burcoglu, Julianne, et al.
Publicado: (2015)

Reversible phosphorylation of the 26S proteasome
por: Guo, Xing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_88rn2jqccor819b4bq7v6narf2